Journal of Biological Chemistry · 2001 · 74 citations · 50 references
Life SciencesGeneticsMolecular BiologyGene ExpressionNeoplasiaOncogenesMyc Family OncogenesNeoplastic TransformationOncogene ActivationTranscription Factor OncogenesTumor Suppressor GenesC-myc RegulationMyc OncogenesMyc-dependent Cell Proliferation
We have identified a novel c-Myc-responsive gene, named JPO1, by representational difference analysis.JPO1 responds to two inducible c-Myc systems and behaves as a direct c-Myc target gene. JPO1 mRNA expression is readily detectable in the thymus, small intestine, and colon, whereas expression is relatively low in spleen, bone marrow, and peripheral leukocytes. We cloned a full-length JPO1 cDNA that encodes a 47-kDa nuclear protein. To determine the role of JPO1 in Myc-mediated cellular phenotypes, stable Rat1a fibroblasts overexpressing JPO1 were tested and compared with transformed Rat1a-Myc cells. Although JPO1 has a diminished transforming activity as compared with c-Myc, JPO1 complements a transformation-defective Myc Box II mutant in the Rat1a transformation assay. This complementation provides evidence for a genetic link between c-Myc and JPO1. Similar to c-Myc, JPO1 overexpression enhances the clonogenicity of CB33 human lymphoblastoid cells in methylcellulose assays. These observations suggest that JPO1 participates in c-Myc-mediated transformation, supporting an emerging concept that c-Myc target genes constitute nodal points in a network of pathways that lead from c-Myc to various Myc-related phenotypes and ultimately to tumorigenesis. We have identified a novel c-Myc-responsive gene, named JPO1, by representational difference analysis.JPO1 responds to two inducible c-Myc systems and behaves as a direct c-Myc target gene. JPO1 mRNA expression is readily detectable in the thymus, small intestine, and colon, whereas expression is relatively low in spleen, bone marrow, and peripheral leukocytes. We cloned a full-length JPO1 cDNA that encodes a 47-kDa nuclear protein. To determine the role of JPO1 in Myc-mediated cellular phenotypes, stable Rat1a fibroblasts overexpressing JPO1 were tested and compared with transformed Rat1a-Myc cells. Although JPO1 has a diminished transforming activity as compared with c-Myc, JPO1 complements a transformation-defective Myc Box II mutant in the Rat1a transformation assay. This complementation provides evidence for a genetic link between c-Myc and JPO1. Similar to c-Myc, JPO1 overexpression enhances the clonogenicity of CB33 human lymphoblastoid cells in methylcellulose assays. These observations suggest that JPO1 participates in c-Myc-mediated transformation, supporting an emerging concept that c-Myc target genes constitute nodal points in a network of pathways that lead from c-Myc to various Myc-related phenotypes and ultimately to tumorigenesis. representational difference analysis Dulbecco's modified Eagle's medium Iscove's modified Dulbecco's medium 4-OH-tamoxifen cycloheximide endoplasmic reticulum ornithine decarboxylase murine Moloney leukemia virus c-myc was first identified as the cellular homologue of the v-myc oncogene in the avian myelocytomatosis retrovirus, MC29 (1Bishop J.M. Adv. Cancer Res. 1982; 37: 1-32Crossref PubMed Scopus (99) Google Scholar). Since its discovery, c-myc has been implicated in numerous human and animal tumors (2Nesbit C.E. Tersak J.M. Prochownik E.V. Oncogene. 1999; 18: 3004-3016Crossref PubMed Scopus (981) Google Scholar, 3Cole M.D. Annu. Rev. Genet. 1986; 20: 361-384Crossref PubMed Scopus (624) Google Scholar). In cases of Burkitt's lymphoma, the c-myc gene on chromosome 8 is translocated to chromosome 2, 14, or 22 placing c-myc under the regulation of the immunoglobulin regulatory elements and leading to sustained elevated levels of c-Myc expression (4Battey J. Moulding C. Taub R. Murphy W. Stewart T. Potter H. Lenoir G. Leder P. Cell. 1983; 34: 779-787Abstract Full Text PDF PubMed Scopus (496) Google Scholar, 5Dalla-Favera R. Bregni M. Erikson J. Patterson D. Gallo R.C. Croce C.M. Proc. Natl. Acad. Sci. U. S. A. 1982; 79: 7824-7827Crossref PubMed Scopus (1345) Google Scholar). Elevated c-Myc expression also arises from genomic amplification of c-myc in breast cancer, lung, cervix, and colon carcinomas (6Little C.D. Nau M.M. Carney D.N. Gazdar A.F. Minna J.D. Nature. 1983; 306: 194-196Crossref PubMed Scopus (667) Google Scholar, 7Munzel P. Marx D. Kochel H. Schauer A. Bock K.W. J. Cancer Res. Clin. Oncol. 1991; 117: 603-607Crossref PubMed Scopus (38) Google Scholar, 8Deming S.L. Nass S.J. Dickson R.B. Trock B.J. Br. J. Cancer. 2000; 83: 1688-1695Crossref PubMed Scopus (233) Google Scholar). More recently, mutations in the adenomatous polyposis coli (APC) pathway that lead to increased Myc levels have been identified in colon cancers (9He T.C. Sparks A.B. Rago C. Hermeking H. Zawel L. da Costa L.T. Morin P.J. Vogelstein B. Kinzler K.W. Science. 1998; 281: 1509-1512Crossref PubMed Scopus (4121) Google Scholar, 10Kolligs F.T. Hu G. Dang C.V. Fearon E.R. Mol. Cell. Biol. 1999; 19: 5696-5706Crossref PubMed Google Scholar, 11Kolligs F.T. Kolligs B. Hajra K.M. Hu G. Tani M. Cho K.R. Fearon E.R. Genes Dev. 2000; 14: 1319-1331PubMed Google Scholar). c-Myc belongs to the family of basic helix-loop-helix leucine zipper transcription factors. c-Myc heterodimerizes with a partner protein, Max, through the C-terminal helix-loop-helix Zip domain (12Blackwood E.M. Eisenman R.N. Science. 1991; 251: 1211-1217Crossref PubMed Scopus (1497) Google Scholar, 13Luscher B. Larsson L.G. Oncogene. 1999; 18: 2955-2966Crossref PubMed Scopus (166) Google Scholar), and together Myc and Max bind DNA specifically (14Blackwell T.K. Kretzner L. Blackwood E.M. Eisenman R.N. Weintraub H. Science. 1990; 250: 1149-1151Crossref PubMed Scopus (704) Google Scholar, 15Blackwell T.K. Huang J. Ma A. Kretzner L. Alt F.W. Eisenman R.N. Weintraub H. Mol. Cell. Biol. 1993; 13: 5216-5224Crossref PubMed Scopus (338) Google Scholar) to activate transcription through the core sequence 5′-CA(C/T)GTG-3′, also known as an E box (16Kato G.J. Barrett J. Villa-Garcia M. Dang C.V. Mol. Cell. Biol. 1990; 10: 5914-5920Crossref PubMed Scopus (316) Google Scholar, 17Kretzner L. Blackwood E.M. Eisenman R.N. Curr. Top. Microbiol. Immunol. 1992; 182: 435-443PubMed Google Scholar). The N-terminal transactivation domain of c-Myc contains two highly conserved regions among the Myc family of proteins; these regions are termed Myc Box I (c-Myc residues 45–63) and Myc Box II (c-Myc residues 128–143) (16Kato G.J. Barrett J. Villa-Garcia M. Dang C.V. Mol. Cell. Biol. 1990; 10: 5914-5920Crossref PubMed Scopus (316) Google Scholar). Despite the wealth of knowledge that has accumulated about c-Myc, the connection between elevated c-Myc levels and oncogenesis remains incompletely understood (18Facchini L.M. Penn L.Z. FASEB J. 1998; 12: 633-651Crossref PubMed Scopus (334) Google Scholar, 19Zindy F. Eischen C.M. Randle D.H. Kamijo T. Cleveland J.L. Sherr C.J. Roussel M.F. Genes Dev. 1998; 12: 2424-2433Crossref PubMed Scopus (1070) Google Scholar). Presumably, the role of Myc as a transcription factor involves regulation of a set of genes that participate in the oncogenic process (20Dang C.V. Mol. Cell. Biol. 1999; 19: 1-11Crossref PubMed Scopus (1417) Google Scholar, 21Grandori C. Eisenman R.N. Trends Biochem. Sci. 1997; 22: 177-181Abstract Full Text PDF PubMed Scopus (248) Google Scholar, 22Grandori C. Cowley S.M. James L.P. Eisenman R.N. Annu. Rev. Cell Dev. Biol. 2000; 16: 653-699Crossref PubMed Scopus (1063) Google Scholar). A number of c-Myc target genes have been identified, including CAD (23Boyd K.E. Farnham P.J. Mol. Cell. Biol. 1997; 17: 2529-2537Crossref PubMed Scopus (141) Google Scholar), ODC (24Bello-Fernandez C. Packham G. Cleveland J.L. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 7804-7808Crossref PubMed Scopus (690) Google Scholar, 25Wu S. Pena A. Korcz A. Soprano D.R. Soprano K.J. Oncogene. 1996; 12: 621-629PubMed Google Scholar),LDH-A (26Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 6658-6663Crossref PubMed Scopus (892) Google Scholar, 27Hubank M. Schatz D.G. Nucleic Acids Res. 1994; 22: 5640-5648Crossref PubMed Scopus (781) Google Scholar), cyclin E (28Perez-Roger I. Solomon D.L. Sewing A. Land H. Oncogene. 1997; 14: 2373-2381Crossref PubMed Scopus (201) Google Scholar), MrDb (29Grandori C. Mac J. Siebelt F. Ayer D.E. Eisenman R.N. EMBO J. 1996; 15: 4344-4357Crossref PubMed Scopus (188) Google Scholar), telomerase/hTERT (30Wang J. Xie L.Y. Allan S. Beach D. Hannon G.J. Genes Dev. 1998; 12: 1769-1774Crossref PubMed Scopus (578) Google Scholar, 31Greenberg R.A. O'Hagan R.C. Deng H. Xiao Q. Hann S.R. Adams R.R. Lichtsteiner S. Chin L. Morin G.B. DePinho R.A. Oncogene. 1999; 18: 1219-1226Crossref PubMed Scopus (361) Google Scholar, 32Horikawa I. Cable P.L. Afshari C. Barrett J.C. Cancer Res. 1999; 59: 826-830PubMed Google Scholar, 33Takakura M. Kyo S. Kanaya T. Hirano H. Takeda J. Yutsudo M. Inoue M. Cancer Res. 1999; 59: 551-557PubMed Google Scholar, 34Wick M. Zubov D. Hagen G. Gene (Amst.). 1999; 232: 97-106Crossref PubMed Scopus (259) Google Scholar, 35Wu K.J. Grandori C. Amacker M. Simon-Vermot N. Polack A. Lingner J. Dalla-Favera R. Nat. Genet. 1999; 21: 220-224Crossref PubMed Scopus (783) Google Scholar), rcl (36Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (135) Google Scholar),IRP2 (37Wu K.J. Polack A. Dalla-Favera R. Science. 1999; 283: 676-679Crossref PubMed Scopus (284) Google Scholar), and cdc25A (38Galaktionov K. Chen X. Beach D. Nature. 1996; 382: 511-517Crossref PubMed Scopus (649) Google Scholar). The use of cDNA microarrays has enlarged the list of potential c-Myc-responsive genes (39Schuhmacher M. Kohlhuber F. Holzel M. Kaiser C. Burtscher H. Jarsch M. Bornkamm G.W. Laux G. Polack A. Weidle U.H. Eick D. Nucleic Acids Res. 2001; 29: 397-406Crossref PubMed Scopus (273) Google Scholar, 40Coller H.A. Grandori C. Tamayo P. Colbert T. Lander E.S. Eisenman R.N. Golub T.R. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 3260-3265Crossref PubMed Scopus (722) Google Scholar, 41Guo Q.M. Malek R.L. Kim S. Chiao C. He M. Ruffy M. Sanka K. Lee N.H. Dang C.V. Liu E.T. Cancer Res. 2000; 60: 5922-5928PubMed Google Scholar, 42O'Hagan R.C. Schreiber-Agus N. Chen K. David G. Engelman J.A. Schwab R. Alland L. Thomson C. Ronning D.R. Sacchettini J.C. Meltzer P. DePinho R.A. Nat. Genet. 2000; 24: 113-119Crossref PubMed Scopus (120) Google Scholar). Despite the long list of c-Myc-responsive genes, the biological effects of these genes in c-Myc related phenotypes are largely unknown. Initial work in our laboratory relied on representational difference analysis (RDA)1 to identify novel putative c-Myc target genes that could be involved in cellular transformation. The screen made use of Rat1a fibroblasts that can be transformed by c-Myc alone (43Small M.B. Hay N. Schwab M. Bishop J.M. Mol. Cell. Biol. 1987; 7: 1638-1645Crossref PubMed Scopus (111) Google Scholar). Unlike parental cells, Rat1a-Myc cells have an increased growth rate, are capable of anchorage-independent growth, form colonies in a soft agar assay (44Hoang A.T. Lutterbach B. Lewis B.C. Yano T. Chou T.Y. Barrett J.F. Raffeld M. Hann S.R. Dang C.V. Mol. Cell. Biol. 1995; 15: 4031-4042Crossref PubMed Scopus (124) Google Scholar), are tumorigenic, and undergo apoptosis in response to growth factor or glucose withdrawal (45Evan G.I. Wyllie A.H. Gilbert C.S. Littlewood T.D. Land H. Brooks M. Waters C.M. Penn L.Z. Hancock D.C. Cell. 1992; 69: 119-128Abstract Full Text PDF PubMed Scopus (2830) Google Scholar, 46Shim H. Chun Y.S. Lewis B.C. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 1511-1516Crossref PubMed Scopus (257) Google Scholar). Our original screen identified genes (36Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (135) Google Scholar). We have named the highly of these JPO1. the of human JPO1 and its in the of The role of JPO1 in transformation and anchorage-independent growth is by its complementation with a transformation-defective c-Myc Box II mutant in Rat1a transformation assays. and and cDNA was with human that colonies were identified and to the with the that was to the of to The JPO1 and cloned by (36Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (135) Google Scholar) were as for were from DNA the in the and and were in with an from were to on an 8 with as JPO1 levels were to by of by was to on a and to were with cDNA with the II JPO1 and were from the identified by JPO1 was from the cDNA in c-myc was from was by were made by cells in and for was by a and of were in of protein, were to on and to were with and with in the were were with in JPO1 were were with in were with and to was with and by of the Rat1a cells were in low glucose and cells S. J.M. Cell 1997; Google Scholar) were in glucose cells M. D. K.R. Bishop J.M. Nature. PubMed Scopus Google Scholar, T.D. Hancock D.C. G.I. Nucleic Acids Res. 1995; PubMed Scopus Google Scholar) were in with CB33 cells of R. an virus cells, and and were in cells and cells, a murine were in glucose were with and and were to by cells in a of and for to were points cells were by the of The is by of 4-OH-tamoxifen to the is by of cycloheximide to the to cells were in glucose to on and were with DNA and in glucose cells were and were for to were in for 8 and in for cells were for in with in the to JPO1 were the was a were with and in with were by JPO1 cDNA was by the from identified in the screen the from the to JPO1. This cDNA was the I of a expression S. I. Nucleic Acids Res. 16: PubMed Scopus Google Scholar) with a modified of JPO1 in is from the The JPO1 was with I on the for the expression JPO1 sequence was by in is from the long cells were by with or expression were with an or a of were CB33 cells were in the of 8 with or from cells. were cells and CB33 cells were in or agar were by cells in a of a of in a A of was and was by or by the use of an that colonies and the were by cells and to of a and were to for and of the was from a with a were in a with an for the of were in a for to were the of of were and or were by The of and JPO1 was identified as a gene in an of Rat1a-Myc fibroblasts (36Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (135) Google Scholar). The to human human JPO1 cDNA was cloned from a human cDNA as a The of the identified in the screen was in was from the to determine that is to the sequence by amplification of cDNA were the sequence was by a that genomic JPO1 The sequence of full-length JPO1 cDNA is in A. of the cDNA a that contains a putative leucine zipper and a A of the known with to JPO1. The JPO1 number is Rat1a cells are an c-Myc these cells are to in and in The of cellular on JPO1 levels was by analysis of mRNA from and Rat1a and Rat1a-Myc We as an for mRNA that c-Myc levels in fibroblasts (36Lewis B.C. Shim H. Li Q. Wu C.S. Lee L.A. Maity A. Dang C.V. Mol. Cell. Biol. 1997; 17: 4967-4978Crossref PubMed Scopus (135) Google levels are in cells as compared with cells. To the expression in cells, the assay that a in Rat1a-Myc fibroblasts in the Rat1a fibroblasts c-Myc expression the levels of JPO1 in and cells, the expression is in cells. JPO1 levels were compared with c-Myc levels in The is a of the cells were by of c-myc gene from cells in a S. J.M. Cell 1997; Google Scholar). mRNA of the cells have been by a in levels that with cells has been on the of as by S. J.M. Cell 1997; Google Scholar). for cells have levels of cells, expression of c-Myc in cells is for of JPO1 expression The between c-Myc and JPO1 expression also to human Although have a between c-Myc levels and JPO1 mRNA levels in these cells to determine is a the We a JPO1 that the human by the between c-Myc and JPO1 levels in human lymphoblastoid CB33 cells, CB33 overexpressing c-Myc Burkitt's and in a of breast A was to determine JPO1 levels were elevated as a of c-Myc cells, in c-Myc is under the of the were with The c-Myc is elevated and from to from cells the that JPO1 as by is elevated for the that JPO1 is a c-Myc To determine JPO1 is a direct or an target of c-Myc, the was These cells are with a of c-Myc and the domain of the T.D. Hancock D.C. G.I. Nucleic Acids Res. 1995; PubMed Scopus Google Scholar). This remains in the by to the the of the protein, its the to and c-Myc target of cells with the the of genes expression on c-Myc transactivation and on an that by mRNA in cells with and in cells with and can between direct and JPO1 levels were in cells a with or We as a and H. Chun Y.S. Lewis B.C. Dang C.V. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 1511-1516Crossref PubMed Scopus (257) Google Scholar) have that mRNA levels with of cells. In levels to a with alone JPO1 JPO1 levels by with and a in JPO1 levels that is sustained to the with These that JPO1 behaves as a direct c-Myc target gene. The expression levels in various human were by a human levels were to be in small and was highly in thymus, lung, colon, and In to the expression in thymus, JPO1 levels were low in bone marrow, spleen, and peripheral leukocytes. JPO1 genomic DNA were as for in to the of JPO1. JPO1 to chromosome as the of the by from the to that to JPO1 has analysis of that JPO1 is a 47-kDa The of JPO1 was by of cells. to JPO1 nuclear in cells. of nuclear are The of cells nuclear of the cells a nuclear that with nuclear cells and cells is also with and is on the of Since JPO1 expression is highly elevated in cells, to determine JPO1 overexpression is to Myc-related Rat1a cells were with cDNA from the in the CB33 human cells were with that JPO1 from the long of stable cells were with levels of JPO1 expression and stable was identified that JPO1 of JPO1 cellular growth in Rat1a or CB33 cells of JPO1 in the of cells to apoptosis was in cells. growth in growth in low glucose to in levels of apoptosis as compared with the parental The of Rat1a cells to and the clonogenicity of CB33 cells were tested in the soft agar growth assay. Rat1a-Myc cells form colonies in soft cells also form colonies in assay about the number of colonies that Rat1a-Myc cells form be that Rat1a by JPO1 is as compared with c-Myc, The of JPO1 colonies is that of c-Myc as of the or JPO1 colonies the assay whereas of the colonies by Rat1a-Myc cells To the of JPO1 to clonogenicity of human lymphoblastoid cells, and cells were tested for in was for Rat1a cells, overexpression of JPO1 or c-Myc increased in CB33 cells and In to the diminished activity of JPO1 in Rat1a cells, JPO1 expression in CB33 cells for to that of CB33 or cells. Although JPO1 anchorage-independent growth, activity is for as in the with Rat1a-Myc cells tumors with of with cells form are cells. Although JPO1 clonogenicity of CB33 cells and a diminished anchorage-independent in Rat1a cells, JPO1 overexpression is for These observations suggest that c-Myc target genes in to JPO1 are for by To determine the role JPO1 in Myc-mediated transformation of Rat1a cells, a Myc mutant that potential transcription Rat1a cells L.A. Dang C.V. Curr. Top. Microbiol. Immunol. 1997; Google Scholar). the to transcription of Myc target genes and is to the transcription of target genes to the as A. the expression of JPO1 is in cells This to JPO1 could the transformation of cells. The and a were with or The soft agar transformation of these cells was The has diminished soft agar transforming as compared with cells. In these the and Rat1a cells a of of Myc or with JPO1 the of as compared with cells that Myc alone or alone The transformation of JPO1 and was with that of Myc the that JPO1 activity can in the in The of c-Myc target genes that are to Myc remains a This is by the of analysis of gene has of putative c-Myc-responsive the of these putative c-Myc-responsive genes a role in Myc remains unknown. the of expression of genes on the to determine c-Myc target genes that participate in the anchorage-independent growth by overexpression of c-Myc in Rat1a cells. A novel gene, JPO1, was identified as a highly in a representational difference analysis of Rat1a Rat1a-Myc cells. In that JPO1 expression with c-Myc expression in numerous evidence as a Myc target gene is by the that cells have levels of JPO1 that are expression of behaves as a direct c-Myc target in the In from suggest is a direct c-Myc target gene. In JPO1 is highly in and small JPO1 expression is low in spleen, bone marrow, and peripheral that levels of JPO1 expression be to cells and that the levels of JPO1 expression be for the of to chromosome by in and are in the of These were in two cases of S. K. U. M. M. P. M. Genes Cancer. 1995; 13: PubMed Scopus Google Scholar, S. N. M. Cancer Genet. 1996; 90: Full Text PDF PubMed Scopus Google Scholar), of leukemia A. N. A. B. F. G. A. G. S. Cancer Genet. Full Text PDF PubMed Scopus Google Scholar), and of leukemia T. K. K.R. K. M. K. K. M. Cancer Genet. 34: Full Text PDF PubMed Scopus Google Scholar). these JPO1 expression remains to be human JPO1 a 47-kDa The of JPO1 was the of of the or in to The JPO1 has to a number of through a Although the to known of the are as These H. I. N. K. T. Mol. Biol. 1996; PubMed Scopus Google Scholar) and from and that the DNA of the in a J. A. I. J. T. T. J. Biochem. 1999; PubMed Scopus Google Scholar). These suggest that a role in DNA and JPO1 be a protein. that JPO1 is a nuclear protein. to a between c-Myc and JPO1 expression in a of human of JPO1 was by in Burkitt's and in a of breast JPO1 was to be in these and to with c-Myc c-Myc overexpression is with human be to determine in JPO1 overexpression is also in these The of JPO1 and c-Myc expression in the that JPO1 participate in Myc-mediated analysis of cells that JPO1 cellular growth to JPO1 is involved in anchorage-independent growth as was by the of cells to form colonies in soft agar or methylcellulose the of cells to of is that overexpression of JPO1 is for the of Rat1a cells as by the JPO1 complements a Myc mutant that has its to form colonies in soft agar and the of JPO1 in anchorage-independent Although is an activity with Myc Box in also in of transactivation of target the Myc Box II mutant ODC K. E.S. P. M. Hay N. Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar). the Myc Box II mutant activate JPO1 whereas of is is that the Myc Box II is for the of the and is for of genes that for transcription M.D. Mol. Cell. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar, Hann S.R. M.D. Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar, M.D. Mol. Cell. Biol. 2000; 20: PubMed Scopus Google Scholar). JPO1 be a gene that for its complementation between JPO1 and the Myc Box II mutant in transformation provides genetic evidence for JPO1 as a target gene of the and of a novel c-Myc JPO1, and its in anchorage-independent The of c-Myc and the of these target genes with Myc-related phenotypes to a by Myc numerous cellular The of c-Myc in of Myc-related phenotypes the that pathways to form a network leading from c-Myc ultimately to with Myc nodal points the We D. G. and of the Dang laboratory for and
50
Induction of apoptosis in fibroblasts by c-myc protein
Gérard I. Evan, Andrew H. Wyllie, Christopher S. Gilbert et al. · Cell · 1992 · 3K citations